Abstract

BackgroundHepatic glycogenosis is characterized by excessive glycogen accumulation in hepatocytes and represents a complication of poor controlled type 1 diabetes. It can be caused by excessive insulin doses or recurrent ketoacidosis episodes. Mauriac’s syndrome is a rare disease, which includes short stature, growth maturation delay, dyslipidemia, moon facies, protuberant abdomen, hepatomegaly with transaminase elevation. It has become even less common after the emergence of advances on diabetes treatment, but still exists. Recent reports described glycogenosis without the full spectrum of Mauriac’s syndrome in both adults and children with brittle diabetes. Clinical, laboratory and histological abnormalities are reversible with appropriate glycemic control.Case presentationWe hereby report a case of 11-year-old male who presented with hepatic glycogenosis mimicking Mauriac’s syndrome. The patient was admitted at our Pediatric Diabetes Clinic for marked hepatomegaly, short stature and for the poor metabolic control. Blood investigations and liver tests excluded most of major causes of hepatopathy. A liver biopsy allowed us to make diagnosis of hepatic glycogenosis. To control hyperglycaemia, initially we titrated daily insulin dosage, and then intravenous insulin treatment was practiced with the consequent normalization of liver enzymes.ConclusionMauriac’s syndrome should be considered in subjects with brittle type 1 diabetes and hepatomegaly.

Highlights

  • Hepatic glycogenosis is characterized by excessive glycogen accumulation in hepatocytes and represents a complication of poor controlled type 1 diabetes

  • Hepatic glycogenosis (HG) is an under recognized condition characterized by pathological storage of glycogen in hepatocytes and represents a rare complication of type 1 diabetes mellitus (T1D) [1]

  • Glycogen reload in the liver was first described in children by Mauriac in 1930 [2, 3] as a component of Mauriac’s syndrome (MS), a rare disease characterized by hepatomegaly with transaminase elevation, puberty and growth failure, dwarfism, dyslipidaemia, reduction of insulin-like growth factor 1, cushingoid features [4]

Read more

Summary

Introduction

Hepatic glycogenosis is characterized by excessive glycogen accumulation in hepatocytes and represents a complication of poor controlled type 1 diabetes. Glycogen reload in the liver was first described in children by Mauriac in 1930 [2, 3] as a component of Mauriac’s syndrome (MS), a rare disease characterized by hepatomegaly with transaminase elevation, puberty and growth failure, dwarfism, dyslipidaemia, reduction of insulin-like growth factor 1, cushingoid features [4]. The majority of reports demonstrated that an adequate management of glucose and daily insulin dosage could lead to a complete remission of clinical, laboratory and histological abnormalities [23].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call